tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SRPT is currently covered by 22 analysts with an average price target of $163.12. This is a potential upside of $44.15 (37.11%) from yesterday's end of day stock price of $118.97.
Sarepta Therapeutics's activity chart (see below) currently has 592 price targets and 540 ratings on display. The stock rating distribution of SRPT is 17.07% HOLD and 82.93% BUY.
Analysts average stock forecasts to be materialized ratio is 60.41% with an average time for these price targets to be met of 281.44 days.
Highest price target for SRPT is $230, Lowest price target is $150, average price target is $163.12.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 27-Nov-2024. First documented stock forecast 20-Mar-2013.
Currently out of the existing stock ratings of SRPT, 21 are a HOLD (17.07%), 102 are a BUY (82.93%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$202
$78.29 (63.29%)
$205
23 days ago
(27-Nov-2024)
12/26 (46.15%)
$66.87 (49.49%)
355
Buy
$193
$69.29 (56.01%)
$200
1 months 13 days ago
(07-Nov-2024)
41/56 (73.21%)
$67.75 (54.09%)
290
Hold
$167
$43.29 (34.99%)
$152
1 months 13 days ago
(07-Nov-2024)
6/13 (46.15%)
$41.75 (33.33%)
112
Buy
$150
$26.29 (21.25%)
$103
1 months 13 days ago
(07-Nov-2024)
3/5 (60%)
$24.75 (19.76%)
274
Buy
$182
$58.29 (47.12%)
$182
1 months 29 days ago
(21-Oct-2024)
16/48 (33.33%)
$54.69 (42.96%)
337
What is SRPT (Sarepta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?
